CCME Global Limited logo

CCME Global Limited (CCME)

Market Closed
16 Oct, 10:00 PM
MSE MSE
₹
37. 09
+1.76
+4.9816%
₹
1.73B Market Cap
- P/E Ratio
- Div Yield
783 Volume
- Eps
₹ 35.33
Previous Close
Add Transaction
Day Range
37.09 37.09
Year Range
26.41 130.1
Want to track CCME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CCME closed today higher at ₹37.09, an increase of 4.9816% from yesterday's close, completing a monthly increase of 3.286% or ₹1.18. Over the past 12 months, CCME stock lost -60.5845%.
CCME is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

CCME Chart

People also search for

Oxygenta Pharmaceutical Ltd.
₹ 47
+1.5997%
Tyche Industries Ltd.
₹ 105.95
+0.6173%
DHP India Ltd.
₹ 486.35
-0.7753%
Parnax Lab Ltd.
₹ 115
+4.3084%
Simmonds Marshall Ltd.
₹ 217.7
+0.1841%

CCME Global Limited (CCME) FAQ

What is the stock price today?

The current price is ₹37.09.

On which exchange is it traded?

CCME Global Limited is listed on MSE.

What is its stock symbol?

The ticker symbol is CCME.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.73B.

Has CCME Global Limited ever had a stock split?

No, there has never been a stock split.

CCME Global Limited Profile

Biotechnology Industry
Healthcare Sector
- CEO
MSE Exchange
- ISIN
India Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Genesis IBRC India Ltd. operates as a diversified holding company with a primary focus on promoting health and wellness. The company secures its position in the health industry by engaging in the healthcare, biotechnology, and nutraceutical sectors through its subsidiaries. It is dedicated to the research, development, and commercialization of wellness products, with a keen emphasis on harnessing biotechnological innovations. As global awareness towards health and the demand for sustainable lifestyle choices surge, Genesis IBRC India Ltd. plays a pivotal role in the preventive healthcare domain. Its activities in the emerging sectors of health and advanced biotechnological solutions reflect the dynamic shifts within the industry, underscoring its commitment to integrating state-of-the-art science in enhancing health outcomes as part of a broader global initiative.

Products and Services

  • Healthcare Services

    At the core of its operations, Genesis IBRC India Ltd. offers comprehensive healthcare services aimed at improving patient care and wellness. This includes diagnostic services, treatment, and personalized healthcare solutions that cater to the specific needs of individuals, thereby elevating the standard of healthcare delivery.

  • Biotechnology Innovations

    The company is deeply involved in biotechnological research and development, focusing on the creation of groundbreaking scientific solutions. These innovations span various applications, from medical treatments to health supplements, driving progress in how diseases are treated and prevented.

  • Nutraceuticals

    Understanding the critical role of nutrition in health and wellbeing, Genesis IBRC India Ltd. develops and markets a variety of nutraceutical products. These products are designed to supplement the diet, support health maintenance, and prevent diseases, reflecting a natural approach towards sustaining health.

Contact Information

Address: VVN Residency
Phone: 91 88 29 256599